Matches in Wikidata for { <http://www.wikidata.org/entity/Q66401909> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q66401909 description "clinical trial" @default.
- Q66401909 description "ensayu clínicu" @default.
- Q66401909 description "klinisch onderzoek" @default.
- Q66401909 description "клінічне випробування" @default.
- Q66401909 name "Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab" @default.
- Q66401909 name "Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab" @default.
- Q66401909 type Item @default.
- Q66401909 label "Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab" @default.
- Q66401909 label "Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab" @default.
- Q66401909 prefLabel "Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab" @default.
- Q66401909 prefLabel "Study to Assess if ABP798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Rituximab" @default.
- Q66401909 P1050 Q66401909-2E50C9BF-1F4A-4373-A4D6-BBB95321CD65 @default.
- Q66401909 P1132 Q66401909-FDC2EF9E-6D5A-4E8C-9C1E-69AF9FE83D86 @default.
- Q66401909 P1476 Q66401909-168C7428-3469-4B63-8D80-FCCCA43A641D @default.
- Q66401909 P17 Q66401909-1FE85DB8-01EF-401B-BE1B-C2FD7D6502DB @default.
- Q66401909 P17 Q66401909-3B5B626F-467E-4003-9898-A2520954AFA5 @default.
- Q66401909 P17 Q66401909-6226737C-FDC3-4AC6-88D5-35FAA412F000 @default.
- Q66401909 P17 Q66401909-B042A5BF-6CD0-4329-8745-A770467E552A @default.
- Q66401909 P17 Q66401909-F1D6F1F3-C365-49F3-8971-E9247AEB6D67 @default.
- Q66401909 P17 Q66401909-FE54D549-F6F3-4EC5-B9DD-4939F8E7B3FA @default.
- Q66401909 P2899 Q66401909-E23C54D3-1F3B-4B79-8BC7-F43FD7E0359E @default.
- Q66401909 P3098 Q66401909-3B7F8E00-0485-4103-B479-4385F75BFB5B @default.
- Q66401909 P31 Q66401909-6A0BE8B7-CDE4-417F-81D6-F9AAA823E460 @default.
- Q66401909 P4135 Q66401909-6B75CD61-7C91-4AB8-87E9-A7813FAB6716 @default.
- Q66401909 P4844 Q66401909-D88A8E74-9521-4F18-BD9D-38859CC04D02 @default.
- Q66401909 P580 Q66401909-6BCCAD5B-AD45-486B-AB97-54CE4A7A9ADA @default.
- Q66401909 P582 Q66401909-667DFD8D-910B-4859-9ACC-A99FC3642EE3 @default.
- Q66401909 P6099 Q66401909-ADECD562-3AAA-4DA4-9746-3CD2C0467526 @default.
- Q66401909 P8363 Q66401909-2CAE353F-231E-4EAF-8947-27B80F97A818 @default.
- Q66401909 P1050 Q170990 @default.
- Q66401909 P1132 "+311" @default.
- Q66401909 P1476 "A Randomized, Double-blind Study to Compare Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of ABP 798 With Rituximab in Subjects With Moderate to Severe Rheumatoid Arthritis" @default.
- Q66401909 P17 Q183 @default.
- Q66401909 P17 Q191 @default.
- Q66401909 P17 Q219 @default.
- Q66401909 P17 Q28 @default.
- Q66401909 P17 Q30 @default.
- Q66401909 P17 Q36 @default.
- Q66401909 P2899 "+18" @default.
- Q66401909 P3098 "NCT02792699" @default.
- Q66401909 P31 Q30612 @default.
- Q66401909 P4135 "+80" @default.
- Q66401909 P4844 Q412323 @default.
- Q66401909 P580 "2016-05-17T00:00:00Z" @default.
- Q66401909 P582 "2018-10-08T00:00:00Z" @default.
- Q66401909 P6099 Q42824827 @default.
- Q66401909 P8363 Q78089383 @default.